Seeking Alpha

M. E. Garza's  Instablog

M.E. Garza is one of the founders of the biotech and healthcare sector news portal BioMedReports.COM.
My business:
BioMedReports.Com
My blog:
biomedreports.com
  • Epix's FDA approved program headed to liquidation auction 0 comments
    Oct 19, 2009 06:12 AM | about stocks: EPIX
    Even as they were announcing their FDA Approval of a Physician-Sponsored IND for Fourth 6-month Open Label Extension of PRX-03140 for Alzheimer's Disease Patients, EPIX Pharmaceuticals, Inc. (OTC:EPIX) plans to quietly wind down operations after a hard fought battle to keep the company afloat.

    The Lexington, Mass.-based company’s officials said Epix was unable to raise enough money or enter into a partnership in time to remain a going concern. Months ago, it had filed paperwork to provide for an orderly liquidation of its assets.

    Back in late July, EPIX Pharmaceuticals entered into an Assignment for the Benefit of Creditors in accordance with Massachusetts state law. The purpose of the Assignment is to conclude their operations and provide for an orderly liquidation of all of its assets.

    The Assignment is a common law business liquidation mechanism under Massachusetts law that is an alternative to a formal bankruptcy proceeding.

    Under the terms of the Assignment, the Company transferred all of its assets to an assignee for orderly liquidation and distribution of the proceeds to the Company's creditors.

    The PRX-03140 program which received the FDA approval will be sold at auction on Wednesday, October 21 at 3 pm. EDT.


    Themes: healthcare, alzheimers Stocks: EPIX
Back To M. E. Garza's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Full index of posts »
Latest Followers
Posts by Ticker

Latest Comments


Most Commented
  1. Novavax's (Nasdaq:NVAX) VLP technology may be big news for mankind (23 Comments)
  2. Closer look at BioElectronics Corporation (OTC:BIEL) Continued (7 Comments)
  3. CDC will stick with "tried and true" methods for flu vaccine production (7 Comments)
  4. Next Big Market: Adult Stem Cell Drugs and Therapies (6 Comments)
  5. Viking Systems: Undervalued and Breaking New Ground (OTC:VKNG) (6 Comments)
Posts by Themes
acetaminophen, Adam Feuerstein, alzheimers, American Scientific Recources, Ampligen, Arthritis, BIEL, Bio Medical, BioElectronics, BioElectronics Corporation, biologics, biomedical, BioSante, biotech, Biotech, Biotechnology, biotechnology, Cancer, Cell Genesys, Chronic Fatigue Syndrome, Clinical Trials, conference, cord blood, Diabetes, FDA, fda, FDA Calendar, flu, Flu, flu stocks, Guardian Technologies International , h1n1, H1N1, H1N1 influenza virus, Healtchcare, health care, Health Care, health-care, Healthcare, healthcare, healthcare biotech, Healthcare. Biotech, HIV, Hoji Alimi, Human Genome Sciences, lab, LEAPS, LibiGel, licensing, Lupus,
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.